Literature DB >> 4738314

Culture conditions affecting induction and release of lymphocyte produced proliferation inhibitory factor (PIF).

A M Badger, S R Cooperband, J A Green.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4738314     DOI: 10.1016/0008-8749(73)90089-0

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  8 in total

1.  I. Evidence that lymphotoxin activity involves both cytotoxic and stimulating factors.

Authors:  A G Ryzewska; B K Darbrowska
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

2.  Lymphokine stimulation of collagen accumulation.

Authors:  R L Johnson; M Ziff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  Characterization of dextran-activated T-cell factors.

Authors:  Y G Alevy; J R Battisto
Journal:  Immunology       Date:  1976-03       Impact factor: 7.397

4.  Lymphocyte proliferation inhibitory factor (PIF) in alcoholic liver disease.

Authors:  T Chen; C M Leevy
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

5.  Cytotoxic activity against rubella-infected cells in the supernatants of human lymphocyte cultures stimulated by rubella virus.

Authors:  G Y Kanra; T Vesikari
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

6.  Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis.

Authors:  R Turcotte; S Lemieux
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes.

Authors:  S S Rich; R R Rich
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

8.  Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.

Authors:  M Castés; N R Lynch; G Lespinats; S Orbach-Arbouys
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.